Miza III Ventures Inc. has recently made headlines with significant corporate changes, including a name change to Neurothera Labs Inc.
This week, Miza III Ventures Inc. (now Neurothera Labs Inc.) remains in focus as it completes its qualifying transaction with SciSparc Ltd. The company has seen an impressive year-to-date performance, yet its trading activity has been notably quiet. Here’s a closer look at the latest developments surrounding the stock.
Advertisement
Miza III Ventures Inc
MIZA-P.V
MIZA-P.V
Miza III Ventures Inc
WealthAwesomeMarket cap
$2.71M
52W high
$5.32
52W low
$0.00
1W change
+0.00%
Beta
0.10
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on MIZA-P's historical volatility
30-Day Vol
2453.4%
Annualized
90-Day Vol
1431.1%
Annualized
Trend (90d)
+50.0%
Annualized drift
90d Mean
C$5.10
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$4.53 | C$0.00 – C$21504.47 |
| 60 trading days | C$4.81 | C$0.00 – C$760557.73 |
| 90 trading days | C$5.10 | C$0.00 – C$11896856.32 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Investor takeaway: Miza III Ventures Inc., now rebranded as Neurothera Labs Inc., is undergoing significant changes. Investors should keep an eye on how these developments impact trading activity and market perception.
Miza III Ventures Inc. Posts YTD Performance of +474344.44%
With a remarkable YTD increase of over 474,000%, Miza III's stock performance raises questions about sustainability and future investor sentiment, especially given its recent corporate changes.
Bull case
The completion of the qualifying transaction could lay a stronger foundation for future growth, particularly with the acquisition of a controlling interest in SciSparc Nutraceuticals Inc.
Bear case
Despite the recent corporate developments, the stock's trading volume remains significantly below average, suggesting a lack of investor interest or confidence.
Recent Corporate Developments
Advertisement
Miza III Ventures Inc. has completed a qualifying transaction with SciSparc Ltd., acquiring a controlling interest in SciSparc Nutraceuticals Inc. This marks a significant milestone for the company, which has also announced its rebranding to Neurothera Labs Inc. effective October 22, 2025. The TSX Venture Exchange has accepted these changes, which are expected to enhance the company’s operational capabilities in the financial sector.
Technical Picture
Miza III Ventures Inc. closed at C$0.30, with a 52-week range of C$0.00 to C$5.32, indicating that the stock is currently trading at about 6% of its 52-week high. The stock has a beta of 0.10, suggesting lower volatility compared to the broader market. Its 50-day moving average stands at C$0.15, showing a significant 104.4% increase compared to the last closing price, while the 200-day moving average is C$0.14, reflecting a 112.4% increase. Notably, the latest trading volume of 428 shares is well below the 20-day average volume of 36,750 shares.
Insider Activity
Currently, there are no reported insider activities for Miza III Ventures Inc., which may indicate a stable management situation as the company transitions under its new branding.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
